MK-1064 R501 ClH/c1-12(16-17-12)6-4-8-15-11(20)14-7-3-2-5-9(13)10(18)19

ClH/c1-12(16-17-12)6-4-8-15-11(20)14-7-3-2-5-9(13)10(18)19

also known as ML029

Formula: C27H38N8O

daily for 4 weeks) increases BMD of DFM at 10mg/kg

33)30-12-10-29(11-13-30)24(31)21-15-28-22-7-6-19(26)14-20(22)23(21)17-2-4-18(5-3-17)25(16-27)8-9-25/h2-7

MK-1064 R501 ClH/c1-12(16-17-12)6-4-8-15-11(20)14-7-3-2-5-9(13)10(18)19MK 1064 is a selective orexin 2 receptor antagonist (2 SORA) for the research of insomnia. target: 2 SORA In vivo: MK 1064 promotes sleep and increases both rapid eye movement (REM) and non REM (NREM) sleep in rats at OX2R occupancies higher than the range observed for dual orexin receptor antagonists. MK 1064 increases NREM and REM sleep in dogs without inducing cataplexy. The reference for animal administration is 30 mg kg. Product information CAS